AES antibody (C-Term)
-
- Target See all AES Antibodies
- AES (Amino-terminal Enhancer of Split (AES))
-
Binding Specificity
- C-Term
-
Reactivity
- Human, Mouse, Rat, Dog
-
Host
- Rabbit
-
Clonality
- Polyclonal
-
Conjugate
- This AES antibody is un-conjugated
-
Application
- Western Blotting (WB)
- Specificity
- AES antibody was raised against the C terminal of AES
- Purification
- Purified
- Immunogen
- AES antibody was raised using the C terminal of AES corresponding to a region with amino acids GLQPPSLPAVSAGTGLLSLSALGSQAHLSKEDKNGHDGDTHQEDDGEKSD
- Top Product
- Discover our top product AES Primary Antibody
-
-
- Application Notes
-
WB: 2.5 µg/mL
Optimal conditions should be determined by the investigator. - Comment
-
AES Blocking Peptide, catalog no. 33R-3414, is also available for use as a blocking control in assays to test for specificity of this AES antibody
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of AES antibody in PBS
- Concentration
- Lot specific
- Buffer
- PBS
- Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Storage
- 4 °C/-20 °C
- Storage Comment
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Target
- AES (Amino-terminal Enhancer of Split (AES))
- Alternative Name
- AES (AES Products)
- Background
- AES is similar in sequence to the amino terminus of Drosophila enhancer of split groucho, a protein involved in neurogenesis during embryonic development. The protein, which belongs to the groucho/TLE family of proteins, can function as a homooligomer or as a heteroologimer with other family members to dominantly repress the expression of other family member genes.
- Molecular Weight
- 22 kDa (MW of target protein)
- Pathways
- WNT Signaling, SARS-CoV-2 Protein Interactome
-